Novo Nordisk: A Story of a Supply Chain Leader
Supply Chain Shaman
FEBRUARY 12, 2017
Note that neither company is making progress at the intersection of operating margin and inventory turns. The level of performance in 2015 is the same as 2006. Performance of BMS and Merck at the Intersection of Inventory Turns and Operating Margin. We are stronger in supply than demand. The patterns are circular.
Let's personalize your content